OMEGA HEALTHCARE INVESTORS, INC. OHI Cash Flow

Omega healthcare investors, inc. (OHI)

CashFlow / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Mar'10
Cash flows from operating activities
Net income
92,279	61,146	142,948	75,671	72,182	64,903	59,062	81,986	87,933	65,156	-137,515	68,157	109,112	129,883	82,134	113,154	58,196	63,543	83,254	43,466	43,052	56,990	61,713	46,817	55,829	47,206	38,137	49,058	38,120	33,923	30,119	30,572	26,084	19,293	21,436	17,790	-5,913	4,969	17,007	15,509	20,951
Adjustment to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
82,643	80,498	76,696	73,637	70,852	70,598	70,711	69,609	70,361	75,323	71,925	70,350	69,993	70,808	68,316	65,505	62,433	60,794	60,143	59,156	30,610	30,401	30,111	31,301	31,444	32,260	32,202	32,225	31,959	30,332	28,305	27,199	27,147	25,489	24,871	24,759	25,218	25,743	27,742	16,451	14,687
Impairment on real estate properties
3,639	-	-	-	-	3,154	22,868	4,078	4,914	63,460	17,837	10,135	7,638	0	17,275	6,893	34,558	3,040	1,743	6,916	5,982	-	-	-	-	-	-	-	-	0	0	0	272	1,373	0	0	24,971	0	0	155	0
Impairment on direct financing leases
-	217	0	0	7,700	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Provision for credit losses
1,486	-	-	-	-	326	-2,015	564	7,814	913	8,590	2,673	2,404	5,878	-3	-1,154	5,124	-	-	-	-2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest - amortization of deferred financing costs
2,461	2,811	2,277	2,238	2,238	2,237	2,238	2,242	2,243	2,243	2,228	12,738	2,502	2,501	4,317	2,210	2,430	22,430	1,857	810	10,730	1,321	-374	3,591	2,962	700	699	-10,414	682	3,189	673	-1,030	7,737	648	3,700	703	694	16,920	978	4,386	978
Accretion of direct financing leases
-6	-	-	-	-10	-	-	-	-33	-32	-25	3,148	3,016	3,158	3,084	2,994	2,921	2,883	2,803	2,707	2,614	2,545	2,478	2,414	2,350	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Stock-based compensation expense
4,635	3,840	2,921	4,040	4,558	3,880	3,962	4,089	4,056	3,862	3,872	3,734	3,744	3,674	3,673	3,665	2,778	4,451	2,199	2,873	1,610	2,022	2,022	2,285	2,263	1,509	1,509	1,472	1,452	1,486	1,485	1,486	1,485	1,519	1,520	1,519	1,479	455	450	467	839
Gain on assets sold - net
1,838	2,893	53,067	-267	3	15,526	-5,361	-2,891	17,500	46,421	693	-622	7,420	30,277	5,139	13,221	1,571	-58	-2,391	8,802	0	0	-20	0	2,883	-	-	-	-	2,826	1,689	1,968	5,316	-	-	-	-	-	-	-	-
Amortization of acquired in-place leases - net
-1,291	-1,231	-1,287	-1,560	-1,826	-3,189	-2,241	-2,590	-2,687	-2,809	-15,303	3,106	3,096	-24,948	3,047	3,610	4,300	9,582	1,381	1,691	1,192	1,207	1,208	1,284	1,287	1,262	1,318	1,199	1,304	1,224	1,236	1,426	1,426	1,448	1,408	4,848	-1,616	-	-	-	0
Effective yield receivable on mortgage notes
87	-85	-85	171	172	179	179	356	354	366	367	598	593	512	-410	-200	819	906	906	1,133	1,120	1,147	1,147	265	319	341	342	529	545	561	561	559	554	409	257	254	421	-	-	-	-
Interest paid-in-kind
1,982	1,891	2,066	1,757	1,446	1,416	1,451	1,602	1,891	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income from unconsolidated joint ventures
-951	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-550	-38	-37	-38	-38	-37	-37	-38	20	-38	23	-98
Change in operating assets and liabilities - net:
Contractual receivables
307	5,775	1,744	-1,108	-480	-103	-702	-6,193	4,630	1,203	2,125	11,916	21,377	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of straight line mortgage interest income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Amortization of in-place leases
-	-	-	-	-	-	-	-	-	-	-	3,106	3,096	-	3,047	3,610	4,300	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accounts receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-560	-	814	-1,325	196	12	3,164	-1,343	431	-928	208	488	-635	441	175	-194	-176	1,818	-339	-109	93	-1,988	652	1,291	90
Straight-line rent receivables
4,784	10,988	11,510	12,790	11,292	14,772	16,041	16,249	14,497	11,681	-9,615	11,427	11,747	12,132	12,203	7,809	9,947	9,492	10,694	10,596	5,275	5,037	5,218	5,377	5,324	6,514	6,683	7,692	6,010	5,659	6,625	6,579	6,541	2,664	3,224	3,269	3,403	4,282	2,967	5,907	-1,946
Lease inducements
13,786	14,718	11,859	5,499	9,995	423	764	-838	32,389	9,761	-447	-448	-447	-647	-648	-647	-647	-647	-675	-1,782	2,110	-647	-647	-647	-715	-850	-545	-843	-842	5,896	-843	-842	-842	5,918	-842	-941	-755	-255	25	512	-276
Other operating assets and liabilities
23,055	-993	11,718	-4,634	23,211	-14,039	10,951	-12,539	50,506	-11,665	5,840	-12,991	36,044	-8,337	-17,698	4,066	19,989	13,000	6,253	1,594	-23,819	3,480	-9,828	-7,752	2,563	-5,163	-11,860	764	8,231	7,207	-11,442	3,814	324	4,270	-5,887	6,389	2,829	-3,867	-894	-1,492	3,491
Operating assets and liabilities for owned and operated properties
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	197	0	-51	98	700	-2,965	-37	81
Net cash provided by operating activities
139,068	147,992	140,343	155,337	110,075	150,908	131,299	164,266	52,900	150,644	163,068	151,653	112,547	167,536	170,342	159,716	127,179	126,612	129,712	89,798	103,294	77,946	92,839	88,699	78,056	79,899	78,722	63,728	57,600	51,304	62,543	44,880	49,544	40,753	51,866	38,446	38,706	47,119	44,506	27,141	38,797
Cash flows from investing activities
Acquisition of real estate
19,085	-	-	-	5,879	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisition of real estate or other
-	-	-	-	-	-	-	-	29,672	-	214,291	123,403	7,574	0	336,900	206,744	416,104	5,892	104,506	177,484	6,300	84,189	25,500	17,300	4,700	-	-	-	-	163,962	205,739	25,070	1,852	-	-	-	-	-	-	-	-
Net proceeds from sale of real estate investments
18,091	33,251	176,963	8,692	356	63,235	24,399	147,207	74,745	188,024	5,727	18,213	45,848	104,857	20,974	41,380	2,392	2	14,695	26,591	255	23	130	293	3,631	-	-	-	-	4,829	2,188	7,938	14,068	-	-	-	-	0	53	0	28
Cash acquired in acquisition
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-113,816	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Investments in construction in progress
27,734	41,491	23,161	44,175	30,851	40,681	35,447	41,458	21,855	17,280	23,301	30,405	15,703	24,870	17,153	10,644	16,316	18,950	129,363	10,062	5,851	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Investments in direct financing leases
-	-	-	-	-	-	-	-	-	232	2,184	2,538	2,229	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from direct financing lease and related trust
-	5,000	0	1,987	86,743	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Placement of mortgage loans
4,269	5,963	5,069	4,425	5,245	3,155	5,241	50,195	6,749	5,319	4,346	19,229	5,749	20,827	15,367	6,366	6,162	6,441	2,900	2,699	2,002	768	437	415,229	113,114	151	358	820	2,049	4,843	2,171	3,646	1,309	140,503	-5,854	-2,858	-1,749	-	-	-	0
Collection of mortgage principal
1,335	11,150	854	42,036	489	476	436	379	24,797	471	385	340	333	1,826	16,098	41,739	312	334	-710	1,447	288	279	5,183	117,390	132	127	121	118	119	12,322	119	124	119	128	-17	-17	-20	138	-15	-15	-30
Investments in unconsolidated joint ventures
495	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Distributions from unconsolidated joint ventures in excess of earnings
179	1,004	5,986	986	1,103	1,064	668	1,859	1,880	1,209	1,225	1,154	8,587	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Capital improvements to real estate investments
12,758	13,352	14,936	14,405	10,199	5,399	5,242	9,587	9,596	12,473	8,432	8,662	8,199	9,063	9,596	12,268	9,544	8,243	6,803	5,747	5,604	5,233	4,322	5,028	3,334	7,615	6,425	8,979	8,328	9,330	5,899	6,222	7,985	7,585	3,894	3,793	4,325	10,367	8,655	7,864	9,139
Receipts from insurance proceeds
311	1,292	1,044	4,458	1,376	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Receipts from insurance proceeds
-	-	-	-	-	-	-	-	1,090	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Investments in other investments
23,813	32,052	54,531	5,591	8,138	10,923	181,822	103,002	89,960	52,972	33,847	30,084	22,144	28,558	106,463	20,533	116,003	15,913	12,889	35,132	1,468	2,730	1,332	1,314	4,065	4,460	1,947	27,280	2,968	5,066	1,113	2,489	1,069	28,659	2,555	1,697	593	0	2,080	34	14,322
Proceeds from other investments
13,084	19,144	21,801	7,965	42,371	19,253	56,423	51,822	53,873	50,651	9,048	12,816	23,181	47,307	23,559	24,462	1,461	8,443	23,222	12,051	2,155	5,637	5,607	1,278	1,067	26,849	1,171	1,172	1,770	3,534	1,781	1,980	8,060	3,797	1,439	767	980	2,604	4,171	14,088	461
Net cash (used in) provided by investing activities
-55,154	-450,484	86,543	-87,138	72,126	-22,667	-144,302	-4,803	-1,447	114,915	-264,195	-152,204	16,351	20,957	-425,897	-35,188	-673,780	-46,660	-226,047	-106,177	-18,527	-86,981	-20,671	-319,910	-120,383	-529,036	-24,838	-33,501	-11,456	-162,516	-210,834	-27,385	10,032	-237,614	-6,697	-7,662	-5,667	-26,030	-8,868	-336,975	-22,942
Cash flows from financing activities
Proceeds from credit facility borrowings
662,466	620,000	206,000	510,000	171,000	288,000	454,000	232,000	317,000	200,000	670,000	669,000	148,000	170,000	255,000	209,000	670,000	122,000	922,000	776,000	6,000	144,000	166,000	470,000	120,000	310,000	0	46,000	155,000	440,000	180,000	47,000	45,000	280,000	115,000	57,000	117,000	71,000	43,000	265,000	6,000
Payments on credit facility borrowings
266,000	495,000	706,000	490,100	289,000	335,000	314,000	367,000	252,000	275,000	460,000	637,000	215,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net proceeds (costs) from issuance of common stock
-	-	-	-	-	-	-	-	-29	-	15,562	-125	6,759	-	-	-	-	-416	-298	17	440,019	-16	4,845	29,334	27,818	118,214	61,895	46,811	51,453	-55	62,099	10,404	5,170	-27	-113	3,242	28,108	1,847	63,409	36,786	36,739
Payments for exercised options and restricted stock
-	-	-	-	-	-	-	-	-	-	-	0	2,120	-	21,023	-1	2,381	538	19,186	5,076	1,906	1,995	639	413	530	-	-	-	-	-	-	-	-	0	0	2,508	-1,254	1,930	0	85	4
Payment of financing related costs incurred by Omega
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	370,000	-	723,000	425,000	91,000	62,000	433,000	200,000	446,000	84,000	5,000	41,000	213,000	284,000	80,000	72,000	290,500	52,500	123,000	73,000	48,000	214,000	121,000	44,000	100,100
Noncontrolling members' contributions to consolidated joint venture
-	-	-	-	228	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Receipts of other long-term borrowings
-	0	492,710	0	2,275	-	-	-	-	-	-	-	-	0	698,173	0	350,000	250,000	598,302	300,000	689,822	0	247,828	0	594,320	100,000	0	0	59,355	0	0	0	400,000	-	-	-	-	583,214	0	0	196,556
Payments of other long-term borrowings
1,845	-	-	-	-	0	0	1,721	328	325	324	1,251,821	318	315	180,314	311	309	599,251	472	1,239,708	347,883	4,512	35,542	1,252	201,238	1,224	1,210	52,211	59,997	1,029	983	12,667	176,007	757	620	612	604	410,596	528	0	59,354
Payments of financing related costs
-	-	-	-	-	0	0	0	8	0	715	27,920	563	60	8,189	5	3,576	24,012	4,586	4,805	21,318	397	4,579	8,585	4,155	2,181	21	226	806	3,974	230	403	12,517	69	3,595	107	534	22,348	407	4,533	4,291
Receipts from dividend reinvestment plan
3,747	23,206	37,742	21,818	32,285	9,897	9,854	22,164	4,886	6,586	10,415	12,386	7,335	10,272	136,436	73,737	19,596	85,182	35,554	24,697	5,414	5,224	20,459	14,264	31,540	8,004	6,233	5,258	36,330	5,782	37,156	54,752	14,224	4,201	14,304	23,088	17,525	103,580	-15,543	-39,740	12,214
Payments for exercised options and restricted stock
3,149	708	653	916	2,279	0	0	0	1,654	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net proceeds from issuance of common stock
1,831	297,819	4,175	26,322	76,547	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Dividends paid
154,603	146,875	143,441	137,178	136,633	132,958	132,717	131,572	131,449	129,179	126,702	124,450	122,272	119,489	116,595	109,568	107,500	105,127	101,718	83,126	68,261	67,232	65,777	63,822	61,670	59,043	55,063	53,431	50,579	49,512	45,661	44,437	42,580	41,438	41,411	38,776	40,268	39,811	36,420	32,053	30,599
Redemption of Omega OP Units
-	-	-	-	-	16	0	46	72	0	0	-8	56	1	722	0	10	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Distributions to Omega OP Unit Holders
7,290	4,208	4,953	5,120	7,013	5,848	5,880	5,880	5,885	5,807	5,676	5,589	5,554	5,441	5,387	5,220	5,131	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Redemption of preferred stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	4	108,552	-	-	-	0
Net cash provided by (used in) financing activities
235,157	292,279	-218,474	-75,174	-152,590	-127,595	10,950	-224,517	-69,539	-203,824	102,560	-18,762	-183,789	-128,406	254,892	-100,879	550,689	-104,202	86,650	-658,651	610,887	13,072	-100,405	239,526	60,085	383,996	6,834	-48,799	-22,244	105,972	152,381	-17,351	-57,210	186,482	-39,435	-29,169	-36,579	-15,360	-36,403	236,597	57,169
Effect of foreign currency translation on cash, cash equivalents and restricted cash
-429	1,361	-318	-287	118	-114	-357	-496	377	159	247	0	162	15	271	-97	-105	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Decrease in cash, cash equivalents and restricted cash
318,642	-8,852	8,094	-7,262	29,729	532	-2,410	-65,550	-17,709	61,894	1,680	-19,313	-54,729	60,102	-392	23,552	3,983	-	-	-	695,654	4,037	-28,237	8,315	17,758	-65,141	60,718	-18,572	23,900	-5,240	4,090	144	2,366	-10,379	5,734	1,615	-3,540	5,729	-765	-73,237	73,024
Interest paid during the period, net of amounts capitalized
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	37,413	36,597	-	29,463	35,244	25,829	34,643	25,898	24,135	26,243	24,868	24,451	25,305	26,092	24,718	23,800	24,160	22,163	23,317	17,495	21,491	16,896	18,526	20,255	13,695	7,814
Taxes paid during the period
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	607	141	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	3,637,251	50,221	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Change in fair value of cash flow hedges
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4,198	8,876	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accrued Dividends
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	50,221	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-cash settlement of mortgage obligations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-24,790	0	24,790	-12,395
Non-cash acquisition of real estate properties
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-24,790	0	0	12,395
Common stock subscription
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-
Omega OP
Net income
92,279	61,146	142,948	75,671	72,182	64,903	59,062	81,986	87,933	65,156	-137,515	68,157	109,112	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation and amortization
82,643	80,498	76,696	73,637	70,852	70,598	70,711	69,609	70,361	75,323	71,925	70,350	69,993	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Impairment on real estate properties
3,639	-	-	-	-	3,154	22,868	4,078	4,914	63,460	17,837	10,135	7,638	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Impairment on direct financing leases
-	217	0	0	7,700	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Provision for credit losses
1,486	-	-	-	-	326	-2,015	564	7,814	913	8,590	2,673	2,404	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest - amortization of deferred financing costs
2,461	2,811	2,277	2,238	2,238	2,237	2,238	2,242	2,243	2,243	2,228	12,738	2,502	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accretion of direct financing leases
-6	-	-	-	-10	-	-	-	-33	-32	-25	3,148	3,016	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Stock-based compensation expense
4,635	3,840	2,921	4,040	4,558	3,880	3,962	4,089	4,056	3,862	3,872	3,734	3,744	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain on assets sold - net
1,838	2,893	53,067	-267	3	15,526	-5,361	-2,891	17,500	46,421	693	-622	7,420	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of acquired in-place leases - net
-1,291	-1,231	-1,287	-1,560	-1,826	-3,189	-2,241	-2,590	-2,687	-2,809	-15,303	3,106	3,096	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Effective yield receivable on mortgage notes
87	-85	-85	171	172	179	179	356	354	366	367	598	593	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest paid-in-kind
1,982	1,891	2,066	1,757	1,446	1,416	1,451	1,602	1,891	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income from unconsolidated joint ventures
-951	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Contractual receivables
307	5,775	1,744	-1,108	-480	-103	-702	-6,193	4,630	1,203	2,125	11,916	21,377	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Straight-line rent receivables
4,784	10,988	11,510	12,790	11,292	14,772	16,041	16,249	14,497	11,681	-9,615	11,427	11,747	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Lease inducements
13,786	14,718	11,859	5,499	9,995	423	764	-838	32,389	9,761	-447	-448	-447	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other operating assets and liabilities
23,055	-993	11,718	-4,634	23,211	-14,039	10,951	-12,539	50,506	-11,665	5,840	-12,991	36,044	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by operating activities
139,068	147,992	140,343	155,337	110,075	150,908	131,299	164,266	52,900	150,644	163,068	151,653	112,547	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisition of real estate
19,085	-	-	-	5,879	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisition of real estate or other
-	-	-	-	-	-	-	-	29,672	-	214,291	123,403	7,574	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net proceeds from sale of real estate investments
18,091	33,251	176,963	8,692	356	63,235	24,399	147,207	74,745	188,024	5,727	18,213	45,848	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Investments in construction in progress
27,734	41,491	23,161	44,175	30,851	40,681	35,447	41,458	21,855	17,280	23,301	30,405	15,703	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Investments in direct financing leases
-	-	-	-	-	-	-	-	-	-	2,184	2,538	2,229	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from direct financing lease and related trust
-	5,000	0	1,987	86,743	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Placement of mortgage loans
4,269	5,963	5,069	4,425	5,245	3,155	5,241	50,195	6,749	5,319	4,346	19,229	5,749	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Collection of mortgage principal
1,335	11,150	854	42,036	489	476	436	379	24,797	471	385	340	333	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Investments in unconsolidated joint ventures
495	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Distributions from unconsolidated joint ventures in excess of earnings
179	1,004	5,986	986	1,103	1,064	668	1,859	1,880	1,209	1,225	1,154	8,587	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Capital improvements to real estate investments
12,758	13,352	14,936	14,405	10,199	5,399	5,242	9,587	9,596	12,473	8,432	8,662	8,199	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Receipts from insurance proceeds
311	1,292	1,044	4,458	1,376	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Receipts from insurance proceeds
-	-	-	-	-	-	-	-	1,090	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Investments in other investments
23,813	32,052	54,531	5,591	8,138	10,923	181,822	103,002	89,960	52,972	33,847	30,084	22,144	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from other investments
13,084	19,144	21,801	7,965	42,371	19,253	56,423	51,822	53,873	50,651	9,048	12,816	23,181	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash (used in) provided by investing activities
-55,154	-450,484	86,543	-87,138	72,126	-22,667	-144,302	-4,803	-1,447	114,915	-264,195	-152,204	16,351	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Repayments of secured borrowings
1,845	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from intercompany loans payable from Omega
662,466	617,725	698,710	510,000	173,275	288,000	454,000	232,000	317,000	200,000	670,000	2,015,749	148,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Repayment of intercompany loans payable to Omega
266,000	470,000	806,000	490,100	289,000	335,000	314,000	368,721	252,328	275,325	460,324	1,888,821	215,318	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payment of financing related costs incurred by Omega
-	-	-	-	-	0	0	0	8	0	715	27,920	563	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Noncontrolling members' contributions to consolidated joint venture
-	-	-	-	228	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Equity contributions from general partners
2,429	320,317	41,264	47,224	106,553	58,227	9,547	49,702	3,203	6,487	25,977	12,261	11,974	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Distributions to general partners
154,603	146,875	143,441	137,178	136,633	132,958	132,717	131,572	131,449	129,179	126,702	124,450	122,272	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Distributions to limited partners
7,290	4,208	4,953	5,120	7,013	5,848	5,880	5,880	5,885	5,807	5,676	5,589	5,554	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Redemption of Omega OP Units
-	-	-	-	-	16	0	46	72	0	0	-8	56	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by (used in) financing activities
235,157	292,279	-218,474	-75,174	-152,590	-127,595	10,950	-224,517	-69,539	-203,824	102,560	-18,762	-183,789	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Effect of foreign currency translation on cash, cash equivalents and restricted cash
-429	1,361	-318	-287	118	-114	-357	-496	377	-	-	-	162	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Increase (decrease) in cash, cash equivalents and restricted cash
318,642	-8,852	8,094	-7,262	29,729	532	-2,410	-65,550	-17,709	-	-	-	-54,729	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-